Delivery Order SPE2DB24D1201-SPE2DB24FJBRE

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $5,777.75 and an ultimate completion date of September 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $15,366.18 and runs through September 11, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) the company holds with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $10,649.87 and runs through September 19, 2024. The contract is for the delivery of pharmaceutical products and is structured as a firm-fixed-price arrangement. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this award. The contract does not have a set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $16,972.70 and a period of performance through November 13, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Eliquis 5 mg tablets. The contract has a ceiling value of $23,179.78 and runs through June 27, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as the...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $8,155.05 and a completion date of December 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of Eliquis 5 mg tablet. The contract has a ceiling value of $11,931.94 and an ultimate completion date of August 15, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded various federal contracts, including an Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $29,480.21 and is a firm fixed price contract with a completion date of September 19, 2024. The contract is not set aside for any specific socioeconomic program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $50,525.05 and a completion date of September 6, 2024. The contract is a Firm Fixed Price type, with no set-aside designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablet 60s. The contract has a ceiling value of $22,163.78 and an ultimate completion date of August 30, 2024. It is a firm-fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJBRE
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $20,061.81 and runs through September 27, 2024. The contract is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by DLA and other agencies to provide a wide range of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies, to support military treatment facilities, veterans' hospitals, and other federal healthcare providers.

Generated 12/26/24, 9:10 AM